Exact Mass: 341.2022

Exact Mass Matches: 341.2022

Found 68 metabolites which its exact mass value is equals to given mass value 341.2022, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Propafenone

1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone

C21H27NO3 (341.1991)


Propafenone is only found in individuals that have used or taken this drug. It is an antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. The drug is generally well tolerated. [PubChem]The electrophysiological effect of propafenone manifests itself in a reduction of upstroke velocity (Phase 0) of the monophasic action potential. In Purkinje fibers, and to a lesser extent myocardial fibers, propafenone reduces the fast inward current carried by sodium ions, which is responsible for the drugs antiarrhythmic actions. Diastolic excitability threshold is increased and effective refractory period prolonged. Propafenone reduces spontaneous automaticity and depresses triggered activity. At very high concentrations in vitro, propafenone can inhibit the slow inward current carried by calcium but this calcium antagonist effect probably does not contribute to antiarrhythmic efficacy. C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BC - Antiarrhythmics, class ic D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents CONFIDENCE standard compound; INTERNAL_ID 2285 D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Propafenone (SA-79), a sodium-channel blocker, acts an antiarrhythmic agent. Propafenone also has high affinity for the β receptor (IC50=32 nM)[1]. Propafenone blocks the transient outward current (Ito) and the sustained delayed rectifier K current (Isus) with IC50 values of 4.9?μm and 8.6?μm, respectively[2]. Propafenone suppresses esophageal cancer proliferation through inducing mitochondrial dysfunction and induce apoptosis[3].

   

Pipernonaline

(2E,8E)-9-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,8-dien-1-one

C21H27NO3 (341.1991)


Pipernonaline is found in herbs and spices. Pipernonaline is an alkaloid from the fruits of Piper longum (long pepper

   

Retrofractamide D

(2E,4E,9E)-10-(2H-1,3-Benzodioxol-5-yl)-N-(2-methylpropyl)deca-2,4,9-trienimidate

C21H27NO3 (341.1991)


Retrofractamide D is an alkaloid from Piper retrofractum (Javanese long pepper). Alkaloid from Piper retrofractum (Javanese long pepper).

   
   

Daphniyunnine E

Daphniyunnine E

C21H27NO3 (341.1991)


   

Deacetylheterophylloidine

Deacetylheterophylloidine

C21H27NO3 (341.1991)


   

2-cyclohexyl-1-oxo-1,4-dihydro-2H-spiro[cyclohexane-1,3-isoquinoline]-4-carboxylic acid

2-cyclohexyl-1-oxo-1,4-dihydro-2H-spiro[cyclohexane-1,3-isoquinoline]-4-carboxylic acid

C21H27NO3 (341.1991)


   

UR-144 N-pentanoic acid

UR-144 N-pentanoic acid

C21H27NO3 (341.1991)


   

daphnipaxianine A

daphnipaxianine A

C21H27NO3 (341.1991)


   
   

Phidianidine B

Phidianidine B

C17H23N7O (341.1964)


   
   
   

17alpha-cyanomethylestra-1,3,5(10)-triene-2,3,17-triol 2-methyl ether

17alpha-cyanomethylestra-1,3,5(10)-triene-2,3,17-triol 2-methyl ether

C21H27NO3 (341.1991)


   

3,18-Dioxo-11??-hydroxycona-1,4-diene

3,18-Dioxo-11??-hydroxycona-1,4-diene

C21H27NO3 (341.1991)


   

(2E,8E)-9-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylnona-2,8-dien-1-one

NCGC00347382-02!(2E,8E)-9-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylnona-2,8-dien-1-one

C21H27NO3 (341.1991)


   

Pipernonaline

(2E,8E)-9-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,8-dien-1-one

C21H27NO3 (341.1991)


   

propafenone

propafenone

C21H27NO3 (341.1991)


C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BC - Antiarrhythmics, class ic D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Propafenone (SA-79), a sodium-channel blocker, acts an antiarrhythmic agent. Propafenone also has high affinity for the β receptor (IC50=32 nM)[1]. Propafenone blocks the transient outward current (Ito) and the sustained delayed rectifier K current (Isus) with IC50 values of 4.9?μm and 8.6?μm, respectively[2]. Propafenone suppresses esophageal cancer proliferation through inducing mitochondrial dysfunction and induce apoptosis[3].

   

omega-6-undecenyltyrazolone

omega-6-undecenyltyrazolone

C21H27NO3 (341.1991)


   

pipernonaline_major

pipernonaline_major

C21H27NO3 (341.1991)


   

p-Hydroxynorpropoxyphene

p-Hydroxynorpropoxyphene

C21H27NO3 (341.1991)


   

PC(O-6:0/0:0)[U]

3,5,9-Trioxa-4-phosphapentadecan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (1)-

C14H32NO6P (341.1967)


   

Retrofractamide D

(2E,4E,9E)-10-(2H-1,3-benzodioxol-5-yl)-N-(2-methylpropyl)deca-2,4,9-trienamide

C21H27NO3 (341.1991)


   

Benaprizine

Benaprizine

C21H27NO3 (341.1991)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

(1S,2S,5R)-3-BOC-2-[(TERT-BUTYLDIMETHYLSILYLOXY)METHYL]-4-OXO-3-AZABICYCLO[3.1.0]HEXANE

(1S,2S,5R)-3-BOC-2-[(TERT-BUTYLDIMETHYLSILYLOXY)METHYL]-4-OXO-3-AZABICYCLO[3.1.0]HEXANE

C17H31NO4Si (341.2022)


   

(S)-Propafenone

(S)-Propafenone

C21H27NO3 (341.1991)


   

1-(2-(4-Hydroxyphenoxy)ethyl)-4-((4-methylphenyl)methyl)-4-piperidinol

1-(2-(4-Hydroxyphenoxy)ethyl)-4-((4-methylphenyl)methyl)-4-piperidinol

C21H27NO3 (341.1991)


   

3,5-diethyl-2-(3-hydroxypropylamino)-5-methyl-6H-benzo[h]quinazolin-4-one

3,5-diethyl-2-(3-hydroxypropylamino)-5-methyl-6H-benzo[h]quinazolin-4-one

C20H27N3O2 (341.2103)


   

Diethylaminoethyl diphenylhydroxypropionate

Diethylaminoethyl diphenylhydroxypropionate

C21H27NO3 (341.1991)


   

3-Oxo-23,24-bisnorchola-1,4-dien-22-oate(1-)

3-Oxo-23,24-bisnorchola-1,4-dien-22-oate(1-)

C22H29O3- (341.2117)


   

2-hydroxy-6-[(8Z,11Z)-pentadeca-8,11,14-trienyl]benzoate

2-hydroxy-6-[(8Z,11Z)-pentadeca-8,11,14-trienyl]benzoate

C22H29O3- (341.2117)


   

14-oxo-DoHE(1-)

14-oxo-DoHE(1-)

C22H29O3- (341.2117)


A polyunsaturated hydroxy-fatty acid anion that is the conjugate base of 14-oxo-DoHE, arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

(13S,14S)-epoxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate

(13S,14S)-epoxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate

C22H29O3- (341.2117)


A polyunsaturated fatty acid anion that is the conjugate base of 13S,14S-epoxy-DHA, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(9S,10E,12Z,14E,16S)-9,16-bis(hydroperoxy)octadecatrienoate

(9S,10E,12Z,14E,16S)-9,16-bis(hydroperoxy)octadecatrienoate

C18H29O6- (341.1964)


   

S-12-hydroxyfarnesyl-L-cysteine

S-12-hydroxyfarnesyl-L-cysteine

C18H31NO3S (341.2025)


   

1-(2-Furanyl)-2-(3-heptyl-2-imino-1-benzimidazolyl)ethanol

1-(2-Furanyl)-2-(3-heptyl-2-imino-1-benzimidazolyl)ethanol

C20H27N3O2 (341.2103)


   

1-(4-Ethoxyphenyl)-3-(4-morpholinyl)-2-phenyl-1-propanol

1-(4-Ethoxyphenyl)-3-(4-morpholinyl)-2-phenyl-1-propanol

C21H27NO3 (341.1991)


   

1-(2,3-Dimethylphenoxy)-3-[4-(2-pyridinyl)-1-piperazinyl]-2-propanol

1-(2,3-Dimethylphenoxy)-3-[4-(2-pyridinyl)-1-piperazinyl]-2-propanol

C20H27N3O2 (341.2103)


   

2-morpholin-4-yl-1-[(1R,5S)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]ethanone

2-morpholin-4-yl-1-[(1R,5S)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]ethanone

C20H27N3O2 (341.2103)


   

7-Oxodocosahexaenoate

7-Oxodocosahexaenoate

C22H29O3- (341.2117)


   

17-Oxodocosahexaenoate

17-Oxodocosahexaenoate

C22H29O3- (341.2117)


   

(4Z,7Z,10Z,14E,16Z,19Z)-13-oxodocosa-4,7,10,14,16,19-hexaenoate

(4Z,7Z,10Z,14E,16Z,19Z)-13-oxodocosa-4,7,10,14,16,19-hexaenoate

C22H29O3- (341.2117)


   

(4Z,7Z,10Z,12E,14E)-15-{(2S,3S)-3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,12,14-pentaenoate

(4Z,7Z,10Z,12E,14E)-15-{(2S,3S)-3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,12,14-pentaenoate

C22H29O3- (341.2117)


   

(4Z,7Z,10Z,13Z)-15-{(3R)-3-[(2Z)-pent-2-en-1-yl]oxiran-2-ylidene}pentadeca-4,7,10,13-tetraenoate

(4Z,7Z,10Z,13Z)-15-{(3R)-3-[(2Z)-pent-2-en-1-yl]oxiran-2-ylidene}pentadeca-4,7,10,13-tetraenoate

C22H29O3- (341.2117)


   

(3-Hexoxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Hexoxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C14H32NO6P (341.1967)


   

2-Aminoethyl (2-hydroxy-3-nonoxypropyl) hydrogen phosphate

2-Aminoethyl (2-hydroxy-3-nonoxypropyl) hydrogen phosphate

C14H32NO6P (341.1967)


   

2-(2-Butenoxy)-N-(2-diethylaminoethyl)-4-quinolinecarboxamide

2-(2-Butenoxy)-N-(2-diethylaminoethyl)-4-quinolinecarboxamide

C20H27N3O2 (341.2103)


   

(4Z,8E,10Z,13Z,16Z,19Z)-7-oxodocosahexaenoate

(4Z,8E,10Z,13Z,16Z,19Z)-7-oxodocosahexaenoate

C22H29O3 (341.2117)


An oxodocosahexaenoate that is the conjugate base of (4Z,8E,10Z,13Z,16Z,19Z)-7-oxodocosahexaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoate

(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoate

C22H29O3 (341.2117)


An oxodocosahexaenoate that is the conjugate base of (4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(16S,17S)-epoxy-(4Z,7Z,10Z,12E,14E,19Z)-docosahexaenoate

(16S,17S)-epoxy-(4Z,7Z,10Z,12E,14E,19Z)-docosahexaenoate

C22H29O3 (341.2117)


A docosanoid anion that is the conjugate base of (16S,17S)-epoxy-(4Z,7Z,10Z,12E,14E,19Z)-docosahexaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(4Z,7Z,10Z,14E,16Z,19Z)-13-oxodocosahexaenoate

(4Z,7Z,10Z,14E,16Z,19Z)-13-oxodocosahexaenoate

C22H29O3 (341.2117)


An oxodocosahexaenoate that is the conjugate base of (4Z,7Z,10Z,14E,16Z,19Z)-13-oxodocosahexaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(1s,2s,5s,6r,9r,11r,12s,13s)-8,11-dihydroxy-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-7,14,17-trien-16-one

(1s,2s,5s,6r,9r,11r,12s,13s)-8,11-dihydroxy-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-7,14,17-trien-16-one

C21H27NO3 (341.1991)


   

(1s,2s,3r,5r,6s,10s,16s)-16-hydroxy-2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-14,20-dione

(1s,2s,3r,5r,6s,10s,16s)-16-hydroxy-2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-14,20-dione

C21H27NO3 (341.1991)


   

16-hydroxy-2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-14,20-dione

16-hydroxy-2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-14,20-dione

C21H27NO3 (341.1991)


   

3,18-dioxo-11α-hydroxycona-1,4-diene

NA

C21H27NO3 (341.1991)


{"Ingredient_id": "HBIN006971","Ingredient_name": "3,18-dioxo-11\u03b1-hydroxycona-1,4-diene","Alias": "NA","Ingredient_formula": "C21H27NO3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6468","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1s,5r,8r,9s,11s,13s,14s,17r,18s)-13-hydroxy-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10-dione

(1s,5r,8r,9s,11s,13s,14s,17r,18s)-13-hydroxy-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10-dione

C21H27NO3 (341.1991)


   

10-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)deca-2,4,9-trienimidic acid

10-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)deca-2,4,9-trienimidic acid

C21H27NO3 (341.1991)


   

(1r,3s,5r,8r,9s,11s,14r,17r,18r)-3-hydroxy-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-10,16-dione

(1r,3s,5r,8r,9s,11s,14r,17r,18r)-3-hydroxy-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-10,16-dione

C21H27NO3 (341.1991)


   

11-hydroxy-7,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-14,17-diene-6,16-dione

11-hydroxy-7,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-14,17-diene-6,16-dione

C21H27NO3 (341.1991)


   

(1s,2s,3r,5r,6s,10s,16r)-16-hydroxy-2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-14,20-dione

(1s,2s,3r,5r,6s,10s,16r)-16-hydroxy-2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-14,20-dione

C21H27NO3 (341.1991)


   

(1s,2r,5s,6s,9r,11s,12s,13s)-8,11-dihydroxy-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-7,14,17-trien-16-one

(1s,2r,5s,6s,9r,11s,12s,13s)-8,11-dihydroxy-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-7,14,17-trien-16-one

C21H27NO3 (341.1991)


   

9-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,8-dien-1-one

9-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,8-dien-1-one

C21H27NO3 (341.1991)


   

(2e,4e,9e)-10-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)deca-2,4,9-trienimidic acid

(2e,4e,9e)-10-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)deca-2,4,9-trienimidic acid

C21H27NO3 (341.1991)


   

8,11-dihydroxy-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-7,14,17-trien-16-one

8,11-dihydroxy-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-7,14,17-trien-16-one

C21H27NO3 (341.1991)


   

13-hydroxy-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10-dione

13-hydroxy-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10-dione

C21H27NO3 (341.1991)


   

(1s,2s,5s,9r,11r,12s,13r)-11-hydroxy-7,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-14,17-diene-6,16-dione

(1s,2s,5s,9r,11r,12s,13r)-11-hydroxy-7,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-14,17-diene-6,16-dione

C21H27NO3 (341.1991)


   

(1s,5r,8r,9s,11s,13r,14s,17r,18s)-13-hydroxy-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10-dione

(1s,5r,8r,9s,11s,13r,14s,17r,18s)-13-hydroxy-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10-dione

C21H27NO3 (341.1991)


   

(1s,2s,5s,6s,9r,11r,12s,13r)-8,11-dihydroxy-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-7,14,17-trien-16-one

(1s,2s,5s,6s,9r,11r,12s,13r)-8,11-dihydroxy-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-7,14,17-trien-16-one

C21H27NO3 (341.1991)